Vanessa Louise Jacoby MD
Assistant Professor, Obstetrics & Gynecology, UCSF School of Medicine
Join to view full profile
1001 Potrero AveRM 6D14San Francisco, CA 94110
Phone+1 415-206-5679
Fax+1 415-206-3112
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Vanessa Jacoby, MD is an obstetrician/gynecologist in San Francisco, California. She is currently licensed to practice medicine in California. She is an Assistant Professor at UCSF School of Medicine.
Education & Training
University of California (San Francisco)Residency, Obstetrics and Gynecology, 2001 - 2005- University of California San Francisco School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2003 - 2027
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Publications & Presentations
PubMed
- Lower Urinary Tract Symptoms in Relation to Leiomyoma Volume, Location, and Position in Reproductive-aged Women in the USA.Alison J Huang, Michael Schembri, Harini Raghunathan, Kimberly Kho, Nicole Williams
International Urogynecology Journal. 2025-02-01 - 1 citationsPatterns of peripartum depression and anxiety during the pre-vaccine COVID-19 pandemic.Marie R Altendahl, Liwen Xu, Ifeyinwa Asiodu, W John Boscardin, Stephanie L Gaw
BMC Pregnancy and Childbirth. 2024-04-25 - 14 citationsResearching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.Rachel S Gross, Tanayott Thaweethai, Erika B Rosenzweig, James Chan, Lori B Chibnik
Plos One. 2024-01-01
Press Mentions
New Data: Pregnant Women More Vulnerable to Long COVIDAugust 14th, 2024- Nearly 1-in-10 Pregnant Women with COVID-19 Develop Long COVID, New U.S. Study SaysJuly 24th, 2024
- Nearly 1 in 10 Pregnant Women Who Get COVID Develop Long COVIDJuly 8th, 2024
Grant Support
- UCSF Clinical and Translational Science InstituteUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2026–2033
- Long Term Effectiveness of Uterine Sparing Fibroid TreatmentsHENRY FORD HEALTH SYSTEM2023–2027
- Long Term Effectiveness of Uterine Sparing Fibroid TreatmentsHENRY FORD HEALTH SYSTEM2023–2027
- Letrozole for Treatment of Uterine Fibroids: A randomized, placebo-controlled trialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2027
- Clinical and Translational Science InstituteUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2016–2026